Filter posts

ICYMI: Insights from my time with Vicki Sato at BIO CEO & Investor Conference

At this week’s BIO CEO & Investor Conference the idea of saving the “best for …

FDA’s No. 2 Official Sounds Off on Right to Try, Opioid Crisis

During his first State of the Union address two weeks ago, President Donald Trump expressed …

The Art of the Biotech Deal at BIO CEO & Investor Conference

Professionals from all areas of biotechnology convened for the 20th annual BIO CEO & Investor …

#BIOCEO18: Tackling the Opioid Crisis

Opioid addiction is plaguing communities across the country, leaving in its wake countless victims, devastated …

#BIOCEO18: Paradigm Shift Creating New Opportunities in China

The past few years have been a time of tremendous change in the world’s second …

#BIOCEO18: “A Moment Decades in the Making”

It’s a first-of-its-kind gene therapy ever approved by the U.S. Food and Drug Administration, marking …

BIO Releases Report on Investment in Pain and Addiction Therapeutics

BIO’s Industry Analysis team has released its second report in a new series on the …

High Caliber Investors Flock to BIO CEO & Investor Conference

Today the 20th BIO CEO & Investor Conference opens in New York City amid a …

Voting Opens for BIO CEO and Investor Conference “Buzz of BIO” Contest

Finalists in each of three categories have been named in this year’s Buzz of BIO …

Biotech Investment and Deal-making are Front and Center at #BIOCEO18

The business of making life-saving treatments is fraught with setbacks, challenges and failures. Along the …